Related Articles for PubMed (Select 17509133)

Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa.

Lawn SD, Myer L, Bangani N, Vogt M, Wood R.

BMC Infect Dis. 2007 May 17;7:41.

PMID: 17509133 [PubMed - indexed for MEDLINE]

Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection.

Sidenius N, Sier CF, Ullum H, Pedersen BK, Lepri AC, Blasi F, Eugen-Olsen J.

Blood. 2000 Dec 15;96(13):4091-5.

PMID: 11110678 [PubMed - indexed for MEDLINE]

High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients.

Ostrowski SR, Piironen T, Høyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H.

J Acquir Immune Defic Syndr. 2005 May 1;39(1):23-31.

PMID: 15851910 [PubMed - indexed for MEDLINE]

The prognostic value of the suPARnostic ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms.

Schneider UV, Nielsen RL, Pedersen C, Eugen-Olsen J.

BMC Infect Dis. 2007 Nov 16;7:134.

PMID: 18021410 [PubMed - indexed for MEDLINE]

Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis.

Stephens RW, Nielsen HJ, Christensen IJ, Thorlacius-Ussing O, Sørensen S, Danø K, Brünner N.

J Natl Cancer Inst. 1999 May 19;91(10):869-74.

PMID: 10340907 [PubMed - indexed for MEDLINE]

The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients.

Begum FD, Høgdall CK, Kjaer SK, Christensen L, Blaakaer J, Bock JE, Glud E, Høyer-Hansen G, Ring-Larsen H, Høgdall EV.

Anticancer Res. 2004 May-Jun;24(3b):1981-5.

PMID: 15274388 [PubMed - indexed for MEDLINE]

The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality.

Wittenhagen P, Kronborg G, Weis N, Nielsen H, Obel N, Pedersen SS, Eugen-Olsen J.

Clin Microbiol Infect. 2004 May;10(5):409-15.

PMID: 15113317 [PubMed - indexed for MEDLINE]

Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome.

Ostrowski SR, Ullum H, Goka BQ, Høyer-Hansen G, Obeng-Adjei G, Pedersen BK, Akanmori BD, Kurtzhals JA.

J Infect Dis. 2005 Apr 15;191(8):1331-41. Epub 2005 Mar 14.

PMID: 15776381 [PubMed - indexed for MEDLINE]

Preoperative plasma soluble urokinase plasminogen activator receptor as a prognostic marker in rectal cancer patients. An EORTC-Receptor and Biomarker Group collaboration.

Riisbro R, Christensen IJ, Nielsen HJ, Brünner N, Nilbert M, Fernebro E.

Int J Biol Markers. 2005 Apr-Jun;20(2):93-102.

PMID: 16011039 [PubMed - indexed for MEDLINE]

10:

The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau.

Eugen-Olsen J, Gustafson P, Sidenius N, Fischer TK, Parner J, Aaby P, Gomes VF, Lisse I.

Int J Tuberc Lung Dis. 2002 Aug;6(8):686-92.

PMID: 12150480 [PubMed - indexed for MEDLINE]

11:

Soluble urokinase receptor levels in plasma during 5 years of highly active antiretroviral therapy in HIV-1-infected patients.

Ostrowski SR, Katzenstein TL, Piironen T, Gerstoft J, Pedersen BK, Ullum H.

J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):337-42.

PMID: 15097149 [PubMed - indexed for MEDLINE]

12:

Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.

Riisbro R, Stephens RW, Brünner N, Christensen IJ, Nielsen HJ, Heilmann L, von Tempelhoff GF.

Gynecol Oncol. 2001 Sep;82(3):523-31.

PMID: 11520150 [PubMed - indexed for MEDLINE]

13:

Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy.

Ostrowski SR, Katzenstein TL, Pedersen M, Høyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H.

Scand J Immunol. 2006 Jun;63(6):478-86.

PMID: 16764702 [PubMed - indexed for MEDLINE]

14:

Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.

Lawn SD, Myer L, Bekker LG, Wood R.

AIDS. 2006 Aug 1;20(12):1605-12.

PMID: 16868441 [PubMed - indexed for MEDLINE]

15:

Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy.

Andersen O, Eugen-Olsen J, Kofoed K, Iversen J, Haugaard SB.

J Med Virol. 2008 Feb;80(2):209-16.

PMID: 18098145 [PubMed - indexed for MEDLINE]

16:

Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study.

Fielding KL, Charalambous S, Stenson AL, Pemba LF, Martin DJ, Wood R, Churchyard GJ, Grant AD.

BMC Infect Dis. 2008 Jul 16;8:93.

PMID: 18631397 [PubMed - indexed for MEDLINE]

17:

Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients.

Fernebro E, Madsen RR, Fernö M, Brünner N, Bendahl P, Christensen IJ, Johnson A, Nilbert M.

Eur J Cancer. 2001 Mar;37(4):486-91.

PMID: 11267858 [PubMed - indexed for MEDLINE]

18:

Reduced release of intact and cleaved urokinase receptor in stimulated whole-blood cultures from human immunodeficiency virus-1-infected patients.

Ostrowski SR, Piironen T, Høyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H.

Scand J Immunol. 2005 Apr;61(4):347-56.

PMID: 15853918 [PubMed - indexed for MEDLINE]

19:

Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer.

Riisbro R, Christensen IJ, Piironen T, Greenall M, Larsen B, Stephens RW, Han C, Høyer-Hansen G, Smith K, Brünner N, Harris AL.

Clin Cancer Res. 2002 May;8(5):1132-41.

PMID: 12006529 [PubMed - indexed for MEDLINE]

20:

Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis.

Slot O, Brünner N, Locht H, Oxholm P, Stephens RW.

Ann Rheum Dis. 1999 Aug;58(8):488-92.

PMID: 10419867 [PubMed - indexed for MEDLINE]

Recent Activity